GEFITINIB-250

The medicine is processed with the use of gefitinib and basically belongs to a class of anti-cancer medications known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Geftinat is widely consumed for the treatment of non-small cell lung cancer. This medicine effectively blocks the activity of chemicals, which increases the growth of cancer cells.

Supplied as: Available as 250mg tablets Drug Interactions:

1. Rifampin or phenytoin

2. Cimetidine, ranitidine,esomeprazole, lansoprazole & omeprazole

3. The blood-thinning effects of warfarin may be increased by geftinat and hence, the risk of bleeding may increase

4. Ketoconazole, itraconazole, fluconazole, erythromycin, clarithromycin, ritonavir, nelfinavir, indinavir & nefazodone